Market Tracker

10/13 2:26pm ET

SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 2:26pm ET
 -1.32 / -2.06%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-17.33% 3 years+28.53%
3 months-23.88% 5 years+26.23%
1 year+31.99% Since inception+15.42%
Data through 10/13/2015

Quote Details

Previous close$63.98
Open day’s range62.66 – 65.20
Net asset value (NAV)64.03 (10/12/2015)
Daily volume2,660,139
Average volume (3 months)4,981,888
Data as of 2:26pm ET, 10/13/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+26.23%+20.45%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.011.31
Net assets$2.1B$1.7B
Average market cap$2.0B$33.2B
Average P/E--24.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RDUS Radius Health Inc1.26%
JUNO Juno Therapeutics Inc1.21%
MYGN Myriad Genetics Inc1.21%
INFI Infinity Pharmaceuticals Inc1.19%
MDXG MiMedx Group Inc1.18%
EXEL Exelixis Inc1.18%
BIIB Biogen1.15%
ABBV AbbVie1.14%
ALXN Alexion Pharmaceuticals Inc1.13%
EXAS Exact Sciences Corp1.13%